Evidence map›Paper›PMID 20643068›Full record

ArticleBiophysical journal2010

Implication of sphingomyelin/ceramide molar ratio on the biological activity of sphingomyelinase.

Beate Boulgaropoulos, Heinz Amenitsch, Peter Laggner, Georg Pabst

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Endogenous cortisol excess confers a unique lipid signature and metabolic network.Journal of molecular medicine (Berlin, Germany) · 2021
    Article
  4. Ceramides in Metabolism: Key Lipotoxic Players.Annual review of physiology · 2021
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Ceramides as modulators of cellular and whole-body metabolism.The Journal of clinical investigation · 2011
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Beate BoulgaropoulosInstitute of Biophysics and Nanosystems Research, Austrian Academy of Sciences, Graz, Austria.
Heinz Amenitsch
Peter Laggner
Georg Pabst
Austrian Academy of Sciences · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sphingolipid signaling plays an important, yet not fully understood, role in diverse aspects of cellular life. Sphingomyelinase is a major enzyme in these signaling pathways, catalyzing hydrolysis of sphingomyelin to ceramide and phosphocholine. To address the related membrane dynamical structural changes and their feedback to enzyme activity, we have studied the effect of enzymatically generated ceramide in situ on the properties of a well-defined lipid model system. We found a gel-phase formation that was about four times faster than ceramide generation due to ceramide-sphingomyelin pairing. The gel-phase formation slowed down when the ceramide molar ratios exceeded those of sphingomyelin and stopped just at the solubility limit of ceramide, due to unfavorable pairwise interactions of ceramide with itself and with monounsaturated phosphatidylcholine. A remarkable correlation to in vitro experiments suggests a regulation of sphingomyelinase activity based on the sphingomyelin/ceramide molar ratio.

Indexed as

Bacillus cereusCell MembraneCeramidesHydrolysisPhosphatidylcholinesScattering, Small AngleSphingomyelin PhosphodiesteraseSphingomyelinsX-Ray Diffraction1-palmitoyl-2-oleoylphosphatidylcholineCeramidesPhosphatidylcholinesSphingomyelin PhosphodiesteraseSphingomyelins

Identifiers

PMID20643068
PMCPMC2905085
OpenAlexW2039904623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.